Vancouver, British Columbia--(Newsfile Corp. - October 24, 2014) - OxySure Systems (OTCQB: OXYS), has merged with Estill Medical Technologies, with the combined entity continuing to trade under the symbol OXYS.

InvestmentPitch.com has produced a "video news alert" about OxySure Systems. If this link is not enabled, please visit www.InvestmentPitch.com and enter "OxySure" in the search box.

If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_31ymnwij/OxySure-Systems-OTCQB-OXYS-Merges-with-Estill-Medical-Technologies

OxySure Systems is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions, having pioneered a safe and easy to use solution to produce medically pure oxygen from inert powders. It owns numerous issued patents and patents pending on this technology, which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.

Estill Medical Technologies developed, markets and sells the Thermal Angel blood and intravenous fluid infusion warmer. The Thermal Angel is an FDA-cleared, battery powered, disposable, lightweight and portable device that is used to warm blood or IV fluid at the point of injury or stationary environments.

The combined product portfolio addresses critical needs in both first-responder and pre-responder markets, as well as the military. OxySure plans to be a platform company for additional product and market expansion to enhance its market position and appeal on an expedited timeframe.

Financial highlights of the merger include:

• Combined market size close to $1 billion annually, with about 50% in the US alone
  
  
• The merger creates a combined entity with initial annual revenues expected to be in excess of $10 million
  
  
• Anticipated annual synergies of $2-3 million, improved cash flows and a strengthened balance sheet

This merger also moves OxySure one step closer to its stated goal of uplisting the company to a national exchange.

Julian Ross, OxySure's CEO, stated: "Bringing our two companies together is a great development not only for us, but for our customers, who will benefit from our unique and innovative products, available through a broader, multi-channel, global distribution network. This transaction represents the first step towards enhancing our platform of proven, life-saving products geared towards enabling first-responders."

Jay Lopez, CEO of Estill Medical Technologies added, "Our Thermal Angel is a life-saving medical device used as a standard of care by the U.S. Military, in both combat and non-combat environments. By joining forces with OxySure, we will be able to offer new products to our existing caregivers, patients, and distribution channels.The merger will combine both companies' product development capabilities and sales and marketing networks, with no overlap, strengthening the combined companies' ability to serve customers both domestically and internationally."

Julian Ross will remain as Chairman and CEO, while Jay Lopez will become President and COO.

The company is trading at $0.70, and with 26.1 million shares outstanding, the company is capitalized at $18.3 million. For more information about Estill Medical, please visit www.thermalangel.com. For more information about OxySure, please visit www.oxysure.com. Investor relations is handled by Stonegate Securities, which can be reached at 214-987-4121 or by email at investors@oxysure.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing corporate interviews and three minute videos based on news releases and research reports. Please visit InvestmentPitch.com and browse our extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
604-684-5524
bmorgan@investmentpitch.com